tiprankstipranks
Advertisement
Advertisement

BRTX Stock Latest News

BioRestorative Revamps Board Following New Loan Agreement
Company AnnouncementsBioRestorative Revamps Board Following New Loan Agreement
2d ago
8K
BRTX
BioRestorative Therapies Finalizes Executive Agreement with R&D VP
PremiumCompany Announcements
BioRestorative Therapies Finalizes Executive Agreement with R&D VP
2d ago
8K
BRTX
BioRestorative Therapies Extends Executive Leadership Employment Agreements
PremiumCompany Announcements
BioRestorative Therapies Extends Executive Leadership Employment Agreements
16d ago
8K
BRTX
BioRestorative Therapies shareholder Kaos Capital acquires 4.9% stake
PremiumThe Fly
BioRestorative Therapies shareholder Kaos Capital acquires 4.9% stake
18d ago
BRTX
BioRestorative Therapies completes Phase 2 dosing of BRTX-100
PremiumThe Fly
BioRestorative Therapies completes Phase 2 dosing of BRTX-100
19d ago
BRTX
BioRestorative Therapies presents preclinical data on MSC exosome proteomics
PremiumThe FlyBioRestorative Therapies presents preclinical data on MSC exosome proteomics
1M ago
BRTX
BioRestorative Therapies reports expanded Phase 2 blinded dataset for BRTX-100
Premium
The Fly
BioRestorative Therapies reports expanded Phase 2 blinded dataset for BRTX-100
1M ago
BRTX
BioRestorative Therapies Boosts Executive Compensation and Equity Incentives
Premium
Company Announcements
BioRestorative Therapies Boosts Executive Compensation and Equity Incentives
1M ago
8K
BRTX
BioRestorative Therapies Updates Corporate Presentation for Investors
PremiumCompany Announcements
BioRestorative Therapies Updates Corporate Presentation for Investors
2M ago
8K
BRTX
Best Cheap Stocks to Buy Today: 04/23/26
PremiumMarket News
Best Cheap Stocks to Buy Today: 04/23/26
2M ago
BRTX
IMUX
BioRestorative Therapies announces partnership with David Goldberg, M.D.
PremiumThe Fly
BioRestorative Therapies announces partnership with David Goldberg, M.D.
2M ago
BRTX
BioRestorative: Strong Phase 2 BRTX-100 Data and Upcoming 2027 Catalyst Underpin Buy Rating and Attractive Risk‑Reward
PremiumRatings
BioRestorative: Strong Phase 2 BRTX-100 Data and Upcoming 2027 Catalyst Underpin Buy Rating and Attractive Risk‑Reward
2M ago
BRTX
BioRestorative Therapies announces strategic collaboration with 203 Creates
PremiumThe FlyBioRestorative Therapies announces strategic collaboration with 203 Creates
2M ago
BRTX
BioRestorative Therapies price target lowered to $15 from $18 at Roth Capital
Premium
The Fly
BioRestorative Therapies price target lowered to $15 from $18 at Roth Capital
2M ago
BRTX
BioRestorative Therapies reports blinded data from mesenchymal stem cells trial
Premium
The Fly
BioRestorative Therapies reports blinded data from mesenchymal stem cells trial
3M ago
BRTX
Is BRTX a Buy, Before Earnings?
PremiumPre-Earnings
Is BRTX a Buy, Before Earnings?
3M ago
BRTX
BioRestorative Therapies issues letter to shareholders
PremiumThe Fly
BioRestorative Therapies issues letter to shareholders
3M ago
BRTX
BioRestorative Therapies expands global protection for ThermoStem
PremiumThe Fly
BioRestorative Therapies expands global protection for ThermoStem
4M ago
BRTX
BioRestorative Therapies prices $5.0M public offering of common stock at $0.35
PremiumThe Fly
BioRestorative Therapies prices $5.0M public offering of common stock at $0.35
4M ago
BRTX
BioRestorative Therapies expects to sumbit Phase 3 trial IND in 2H26
PremiumThe FlyBioRestorative Therapies expects to sumbit Phase 3 trial IND in 2H26
4M ago
BRTX
BioRestorative completes patient enrollment in Phase 2 trial of BTRX-100
Premium
The Fly
BioRestorative completes patient enrollment in Phase 2 trial of BTRX-100
4M ago
BRTX
BioRestorative Therapies files to sell 9.71M units
Premium
The Fly
BioRestorative Therapies files to sell 9.71M units
4M ago
BRTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >